"Ioxaglic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A low-osmolar, ionic contrast medium used in various radiographic procedures.
Descriptor ID |
D007485
|
MeSH Number(s) |
D02.241.223.100.400.880.450 D02.455.426.559.389.127.375.880.450
|
Concept/Terms |
Ioxaglate Meglumine- Ioxaglate Meglumine
- Meglumine, Ioxaglate
- Methylglucamine Ioxaglate
- Ioxaglate, Methylglucamine
|
Below are MeSH descriptors whose meaning is more general than "Ioxaglic Acid".
Below are MeSH descriptors whose meaning is more specific than "Ioxaglic Acid".
This graph shows the total number of publications written about "Ioxaglic Acid" by people in this website by year, and whether "Ioxaglic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 2 | 0 | 2 |
2011 | 1 | 0 | 1 |
2014 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ioxaglic Acid" by people in Profiles.
-
Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker. Invest Radiol. 2014 Oct; 49(10):647-52.
-
Evaluation of intrarenal oxygenation in iodinated contrast-induced acute kidney injury-susceptible rats by blood oxygen level-dependent magnetic resonance imaging. Invest Radiol. 2014 Jun; 49(6):403-10.
-
Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. J Allergy Clin Immunol. 2011 Jul; 128(1):219-21.
-
Iodixanol and ioxaglate in adult aortography and peripheral arteriography: a phase III clinical trial. Acad Radiol. 1996 Sep; 3 Suppl 3:S514-8.
-
Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography: a phase III clinical trial. Acad Radiol. 1996 Sep; 3 Suppl 3:S507-13.
-
Safety and efficacy of sodium and meglumine ioxaglate (Hexabrix) and Hypaque M60% in contrast-enhanced computed cranial tomographic scanning. A double-blind clinical study. Invest Radiol. 1987 Jan; 22(1):56-61.